RecallDepth
Class II Terminated

glipiZIDE Extended-Release Tablets, 5 mg, 1000 count bottles, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV --- NDC 0378-0342-10

Company
Mylan Pharmaceuticals Inc.
Recall Initiated
January 19, 2017
Posted
March 8, 2017
Recall Number
D-0491-2017
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
1338 bottles
Firm Location
Morgantown, WV, United States

Reason for Recall

Presence of Foreign Tablets/Capsules; bottles of Glipizide 5 mg tablets may contain Glipizide 10 mg tablets

Distribution

Nationwide

Lot / Code Info

Batch # 3074621, June 2018

More recalls by Mylan Pharmaceuticals Inc.

View all recalls by this company →

Other recent Class II Drug recalls